Chemoradiotheraphy of Esophageal Cancer

REFERENCES

• UKCCCR Anal Cancer Trial Working Party, Author A. Epidermoid anal cancer: results from the UKCCCR ran-domised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin. Lancet 1996; 348: 1049–54.
   Google Scholar
• Albertsson M, Tennvall J, Andersson T, et al. Malignant melanoma of the nasal cavity and nasopharynx treated with cisplatin and accelerated hyperfractionated radiation. Melanoma Res 1992; 2: 101–4.
   PubMedGoogle Scholar
• Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995; 71: 83–91.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000; 355 (9208): 949–55.
   Google Scholar
• Steel GG. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988; 11: 31–53.
   PubMed Web of Science ®Google Scholar
• Tannock IF. Combined modality treatment with radiotherapy and chemotherapy. Radiother Oncol 1989; 61: 83–101.
   Google Scholar
• Albertsson M, Hakansson CH, Mercke C. Effects of cis-dichlorodiammine-platinum (cis-DDP) alone and in combina-tion with ionizing radiation on the oesophageal mucosa. A scanning and transmission electron microscopic study. Scan-ning Microscopy 1987; 1(4): 1861–9.
   Google Scholar
• Albertsson M, Hakansson CH, Palmegren M. Changes in the esophageal epithelium in rabbits treated by cisdichlorodi-amminedeplatinum as studied by electron microscopy. Scan-ning Microsc 1990; 4: 143–9.
   Google Scholar
• Albertsson M, Cwikiel M, Hakansson CH, et al. Response of the esophageal epithelium to concomitant Cis-diammine-dichloroplatinum (II) and radiation treatment. An electron microscopic study in rabbits. Scanning Microsc 1992; 6: 1023–34.
   PubMedGoogle Scholar
• Albertsson M, Cwikiel M, Hakansson CH, et al. Concomitant chemoradiotherapy: response of tracheal and esophageal ep-ithelium in rabbits. An electron microscopic study. Acta Oncol 1992; 31: 789–92.
   Google Scholar
• Cwikiel M, Albertsson M, Hambreus GM. Acute and delayed effects of radiotherapy in patients with oesophageal squamous cell carcinoma treated with chemotherapy, surgery and pre-and postoperative radiotherapy. Acta Oncol 1994; 33: 49–53.
   Google Scholar
• Earlam R, Cunha-Melo JR. Oesophageal squamous cell car-cinoma. Br J Surg 1980; 67: 381-90, 457–61.
   PubMedGoogle Scholar
• Ezdinle E, Gelber R, Desai D, et al. Chemotherapy of ad-vanced esophageal carcinoma. Cancer 1980; 46: 2149–53.
   PubMedGoogle Scholar
• Byfield J, Barone RM, Shar P, et al. Pharmacological require-ments for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil to ftorafur and x-rays. hit J Radiat Oncol Biol Phys 1982; 8: 1923–33.
   PubMed Web of Science ®Google Scholar
• Keane TJ, Harwood AR, Elkahim T. Radical radiation ther-apy with 5-fluorouracil infusion and mitomycin C for oesophageal squamous carcinoma. Radiother Oncol 1985; 4: 205–10.
   Google Scholar
• National Cancer Institute. Cancer statistics review 1973--1987. Cancer 1990; HHS, PHS, NIH Public.
   Google Scholar
• Blot WJ. Cancer of the esophagus: its causes and changing patterns of occurrence. Am Society Clin Oncol 1997; I: 159–63.
   Google Scholar
• Mueller JM, Erasmi H, Stelzner M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845–57.
   PubMed Web of Science ®Google Scholar
• Hagen JA, Peters JH, De Meeser TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993; 106: 583–90.
   Google Scholar
• Skinner DB, Dowlatshahi KD, De Meester TR. Potentially curable cancer of the esophagus. Cancer 1982; 50: 2571.
   PubMedGoogle Scholar
• Isono K, Sato H, Nakayawa K. Result of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411–6.
   Google Scholar
• Kato H, Watanabe H, Tachimori Y, et al. Evaluation of neck lymph node dissection for thoracic carcinoma. Ann Thorac Surg 1991; 51: 931–5.
   PubMedGoogle Scholar
• Isono K, Ochaiai T, Koide Y. More or less surgery for esophageal cancer-indications for extended three-field lymphadenectomy for esophageal cancer. Dis Esophagus 1994; 7: 147–50.
   Google Scholar
• Albertsson M, Ewers SB, Andersson T, et al. Evaluation of the palliative effect of radiotherapy for esophageal carcinoma. Acta Oncol 1989; 28: 267–70.
   PubMed Web of Science ®Google Scholar
• Hankins JR, Cole FN, Ward A, et al. Carcinoma of the esophagus: philosophy for palliation. Ann Thorac Surg 1972; 14: 189–97.
   PubMedGoogle Scholar
• Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–8.
   Google Scholar
• Zieren HU, Mueller JM, Jacobi CA, et al. Adjuvant postoper-ative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective ran-domized study. World J Surg 1995; 19: 444–9.
   PubMed Web of Science ®Google Scholar
• Teniere P, Hay JM, Fingerhut A, et al. Postoperative radia-tion therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esopha-gus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991; 173: 123–30.
   PubMedGoogle Scholar
• Fok M, Sham JST, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: A prospective randomized controlled study. Surgery 1993; 138–147.
   PubMedGoogle Scholar
• Minsky Bruce D. Nonsurgical treatment approaches for esophageal cancer. Am Society Clin Cancer 1997; I: 164–74.
   Google Scholar
• Hambraeus GM, Mercke CE, Willén R, et al. Prognostic factors influencing survival in combined radiotherapy and surgery of squamous cell carcinoma of the esophagus with special reference to a histopathologic grading system. Cancer 1988; 62: 895–904.
   Google Scholar
• Bedard ELR, Inculet RI, Malthaner RA, et al. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma. Cancer 2001; 91: 2423–30.
   PubMed Web of Science ®Google Scholar
• Nygaard K, Hagen S, Hansen HS, et al. Preoperative radio-therapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. J Surg 1992; 16: 1104–9.
   Google Scholar
• Le Prise E, Etienne P, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esopha-gus. Cancer 1994; 73: 1779–84.
   PubMed Web of Science ®Google Scholar
• Urba S, Orringer M, Turrissi A, et al. A randomized trial comparing transhiatal esophagectomy to preoperative concur-rent chemoradiation followed by esophagectomy in locore-gional esophageal carcinoma. Proc Am Soc Clin Oncol 1995; 14: 199.
   Google Scholar
• Bossett JF, Gignoux M, Trioulet JP, et al. Chemoradiother-apy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161–8.
   PubMedGoogle Scholar
• Walsh T, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocar-cinoma. N Engl J Med 1996; 335: 462–7.
   PubMed Web of Science ®Google Scholar
• Leichman L, Steiger L, Seydel HG, et al. Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach. J Clin Oncol 1984; 2: 75–9.
   PubMed Web of Science ®Google Scholar
• Mercke C, Albertsson M, Hambreus G, et al. Cisplatinum and 5-FU combined with radiotherapy and surgery in the treatment of squamous cell carcinoma of the oesophagus: palliative effects and tumour response. Acta Oncol 1991; 30: 617–22.
   PubMed Web of Science ®Google Scholar
• Bates BA, Detterbeck FC, Bernard SA, et al. Concurrent radiation therapy and chemotherapy followed by esophagec-tomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156–63.
   PubMed Web of Science ®Google Scholar
• Carey RW, Hilgenberg AD, Wilkins, Jr EW, et al. Long term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postopera-tive radiotherapy and/or chemotherapy in squamous cell car-cinoma of the esophagus. Cancer Invest 1993; 11: 99–105.
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Preoper-ative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11: 1118–23.
   Google Scholar
• Naunheim KS, Petruska PJ, Roy TS, et al. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995; 59: 1085–91.
   PubMed Web of Science ®Google Scholar
• Wolfe WG, Vaughn AL, Seigler HF, et al. Survival of pa-tients with carcinoma of the esophagus treated with com-bined-modality therapy. J Thorac Cardiovasc Surg 1993; 105: 749–56.
   PubMedGoogle Scholar
• Seydel HG, Leichman L, Byhart, et al. Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus: an RTOG Study. Int J Radiat-Oncol Biol Phys 1988; 14: 33–35.
   PubMedGoogle Scholar
• Poplin E, Fleming T, Leichman L, et al. Combined therapies for squamous cell carcinoma of the esophagus: a Southwest Oncology Group Study (SWOG 8037). J Clin Oncol 1987; 5: 622–8.
   PubMed Web of Science ®Google Scholar
• Stockeld D, Tennvall J, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esopha-gus. Acta Oncol 2001; 40: 566–73.
   PubMed Web of Science ®Google Scholar
• Clark PI. Medical Research Council randomised trial of surgery with or without pre-operative chemotherapy in re-sectable cancer of the oesophagus. Ann Oncol 2000; 11: (Abstr).
   Google Scholar
• Wagner W, Hermann R, Hartlapp J, et al. Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radiochemotherapy and surgery. Strahlelenther Onkol 2000; 176: 73–80.
   PubMedGoogle Scholar
• Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix cancer. Cancer 1999; 86: 1528–63.
   PubMed Web of Science ®Google Scholar
• Coia LR, Engstrom P, Paul A, et al. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary man-agement of esophageal carcinoma. hit J Radiat Oncol Biol Phys 1991; 20: 29–36.
   PubMedGoogle Scholar
• Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemo-radiotherapy vs radiotherapy alone in pa-tients with esophageal cancer: an intergroup study. J Clin Oncol 1997; 15: 277–84.
   Google Scholar
• Albertsson M. A randomised Phase III clinical trial compar-ing surgery alone with chemoradiotherapy alone for localised resectable carcinoma of the oesophagus. Stockholm: Onco-logic Center, 2000.
   Google Scholar
• Cwikiel M, Cwikiel W, Albertsson A. Palliation of dysphagia in patients with malignant esophageal stricture. Comparison of results of radiotherapy, chemotherapy and esophageal stent treatment. Acta Oncol 1996; 35: 75–9.
   Google Scholar
• Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 1995; 42: 507–12.
   PubMed Web of Science ®Google Scholar
• Ilson D, Shah M, O'Reilly E, et al. A phase II trial of weekly one hour paclitaxel followed by bryostatin-1 in patients with advanced esophageal cancer: an active new drug combination. Proc ASCO 2000; 20: 159a.
   Google Scholar
• Albertsson M, Fagerberg J, Jacobsen AB, et al. Preliminary results of a Phase 11 study with taxotere (docetaxel) in pa-tients with primary untreated or recurrent oesophagus cancer. Proc Am Soc Clin Oncol 102000; A181: (Abstr).
   Google Scholar
• Conroy T, Etienne PL, Adenis A, et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal car-cinoma. J Clin Oncol 1996; 1: 164–70.
   Google Scholar
• Spiridonidis CH, Laufman LR, Jones J, et al. Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies. J Clin Oncol 1998; 16: 3866–73.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Bergh J, Brandt L, et al. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types—summary and conclusions. Acta Oncol 2001; 40: 135–54.
   PubMed Web of Science ®Google Scholar